Attitudes Toward Mammography Differ Across Ethnicities, Cultures, Backgrounds
Black and Hispanic women have a different understanding of screening mammography compared with that of Caucasian women.
Ads by Google
Black and Hispanic women have a different understanding of screening mammography compared with that of Caucasian women.
Women who live in cities have denser breasts, making them more likely to develop breast cancer
The presence or absence of two proteins may be important markers for long-term survival in some breast-cancer patients.
A specific biological response to cellular stress may predict the likelihood of future tumor formation of the most common, non-invasive form of pre-malignant breast cancer.
Peregrine Pharmaceuticals's Phase II clinical protocol to study bavituximab in combination with the chemotherapy drug docetaxel in patients with metastatic breast cancer has been approved.
In 2007, more than 178,000 American women will be diagnosed with breast cancer
California Cancer Care, Marin General Hospital, University of California to improve access to surgical services for individuals with breast cancer who reside in Marin County.
A southeast Michigan initiative has increased the number of black women in the area who receive mammograms.
Mammograms or MRIs - which is best for detecting breast cancer early?
Editorial summarizes efforts that address breast cancer issues among minorities.
Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation.
Siemens Medical Solutions completed its first installation of a mobile digital mammography system in the U.S.
A Mayo Clinic study of a drug that has shown promise in treating sarcoma, lung and brain cancers, demonstrates that the drug may also be effective in treating breast cancer.
Breast cancer is an abnormal growth of cells that originates in the milk-producing ducts of the breast.
About 50 percent of women think breast cancer is hereditary, only 10 percent of breast cancer sufferers have a genetic history of the disease.
Sister Study Breast Cancer Research project want to find out what, if anything, distinguishes women who suffer breast cancer from their sisters who do not.
Hormone balance vs. hormone replacement is the hot topic among those who believe breast cancer can be prevented and menopause symptoms treated safely without the use of synthetic.
Saudi women die of breast cancer because they seek treatment too late, said radiologist Asma al-Dabbagh, one of the first women to conduct mammograms in the country.
Patient education decision aids can help older women make better-informed decisions about whether to continue mammography screening.
The breast cancer drugs called taxanes, which include Taxol and Taxotere, increase survival rates when used as part of chemotherapy following surgery for cancers that have not spread.
Illinois First Lady is urging Illinois women to get screened and Tell a Friend about the importance of getting screened for breast cancer.
The number of women who undergo double mastectomies after detection of a tumor in one breast increased by 150% from 1998 to 2003.
Inflammatory breast cancer is primarily noted by a red breast, rather than the traditional lump. If left untreated, it will kill within months.
FDA has approved Ixempra (ixabepilone), a new anti-cancer treatment, for use in patients with metastatic or locally advanced breast cancer.
Women who gain weight throughout adulthood rather than maintaining a stable weight may have an increased risk for breast cancer.
Mammography is an invaluable tool in detecting breast cancer, so it's important that we do everything possible to ensure the quality, safety and reliability of mammography performed in Illinois.
State officials reported that breast cancer incidence and mortality rates in Wisconsin are declining.
Metropolitan Chicago Breast Cancer Task Force addresses a mortality rate gap between black and white women with breast cancer.
FDA approved Bristol-Myers Squibb's chemotherapy drug Ixempra for use as a breast cancer treatment.
Panacea Pharmaceuticals's serum-based breast cancer diagnostic test is now available from Panacea Laboratories. BC Detect is a simple blood test that should facilitate the identification of recurrence among women successfully treated for breast cancer. Panacea Laboratories, a division of Panacea Pharmaceuticals, is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). The blood sample can be ordered by any physician and sent to Panacea for testing; sample and shipping requirements are available at www.panacea-labs.com.